Table 3 Multivariate competing risk regression analysis for local recurrence and distant metastasis, with death as competing event.
Multivariate analysis | Local recurrence | Distant metastasis | Overall survival | |||
|---|---|---|---|---|---|---|
HR (95% CI) | p Value | HR (95% CI) | p Value | HR (95% CI) | p Value | |
Age at surgery (years) | 1.03 (1.02–1.05) | <0.001 | ||||
R1/2 margins (vs. R0 as ref.) | 2.14 (0.94–4.89) | 0.072 | ||||
G1 (ref.) | 1 | |||||
G2 | 2.69 (0.66–11.03) | 0.169 | ||||
G3 | 2.68 (0.69–10.39) | 0.153 | ||||
Tumour size (cm) | 1.06 (1.02–1.11) | 0.003 | 1.04 (0.99–1.08) | 0.076 | ||
MF (ref.) | 1 | |||||
SS | 1.72 (0.59–5.01) | 0.321 | ||||
UPS | 2.69 (1.29–5.62) | 0.008 | ||||
LPS | 0.48 (0.17–1.35) | 0.163 | ||||
Other | 1.57 (0.66–3.75) | 0.307 | ||||
LMS | 2.16 (1.07–4.33) | 0.031 | ||||
CD3+CD4+FOXP3+ Tregs | 1.41 (1.08–1.59) | 0.006 | ||||
FOX3P+ cells | 0.98 (0.96–1.01) | 0.076 | ||||
CD3−PD-L1+ cells | 1.12 (0.98–1.27) | 0.087 | ||||